rapp: the income statement

MyFinsight

Rapport Therapeutics, Inc. (RAPP)

For the quarter ending 2025-06-30, RAPP made $2,783K in revenue. -$26,713K in net income. Net profit margin of -959.86%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Change in unrealized gains (losses) on investments, net of tax	19
Total other comprehensive income (loss)	19
Research and development	22,680
General and administrative	6,816
Total operating expenses	29,496
Loss from operations	-29,496
Interest income	2,764
Total other income, net	2,764
Net loss	-26,732
Comprehensive loss	-26,713

Net loss per share attributable to common stockholders, basic	-0.75
Net loss per share attributable to common stockholders, diluted	-0.75
Weighted average common shares outstanding, basic	35,444,635
Weighted average common shares outstanding, diluted	35,444,635

Unit: Thousand (K) dollars (except for numbers of shares and EPS)